Current Treatment Options for COVID-19 Associated Mucormycosis: Present Status and Future Perspectives

Mucormycosis has become increasingly associated with COVID-19, leading to the use of the term “COVID-19 associated mucormycosis (CAM)”. Treatment of CAM is challenging due to factors such as resistance to many antifungals and underlying co-morbidities. India is particularly at risk for this disease...

Descripción completa

Detalles Bibliográficos
Autores principales: Madhavan, Yasasve, Sai, Kadambari Vijay, Shanmugam, Dilip Kumar, Manimaran, Aashabharathi, Guruviah, Karthigadevi, Mohanta, Yugal Kishore, Venugopal, Divyambika Catakapatri, Mohanta, Tapan Kumar, Sharma, Nanaocha, Muthupandian, Saravanan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9267579/
https://www.ncbi.nlm.nih.gov/pubmed/35806905
http://dx.doi.org/10.3390/jcm11133620

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9267579/
https://www.ncbi.nlm.nih.gov/pubmed/35806905
http://dx.doi.org/10.3390/jcm11133620

Ejemplares similares